Table 4

Hazard ratios for survival in diabetic patients with lung cancer based on their use of metformin and/or a TZD, corrected for stage at presentation and age
HR (95% CI) P-value
Metformin and/or TZD vs. neither 1.22 (0.96, 1.55) 0.30
Metformin alone vs. neither 1.47 (1.12, 1.92) 0.005
TZD alone vs. neither 1.04 (0.65, 1.66) 0.87

Mazzone et al.

Mazzone et al. BMC Cancer 2012 12:410   doi:10.1186/1471-2407-12-410

Open Data